198 related articles for article (PubMed ID: 1657203)
41. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
[TBL] [Abstract][Full Text] [Related]
42. Experience in imaging medullary thyroid carcinoma using 99mTc (V) dimercaptosuccinic acid (DMSA).
Clarke S; Lazarus C; Maisey M
Henry Ford Hosp Med J; 1989; 37(3-4):167-8. PubMed ID: 2576956
[TBL] [Abstract][Full Text] [Related]
43. [The study on the in-vitro stability of Tc(V)-99m dimercaptosuccinic acid].
Lee BF; Chung KL; Jong SB; Yang CC; Chen CL; Chen YJ; Chen SL; Yu HS; Ting G; Shen LH
Kaohsiung J Med Sci; 1996 Sep; 12(9):495-502. PubMed ID: 8819352
[TBL] [Abstract][Full Text] [Related]
44. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA.
Djokić D; Janković D; Nikolić N
Cancer Biother Radiopharm; 2009 Feb; 24(1):129-36. PubMed ID: 19243255
[TBL] [Abstract][Full Text] [Related]
45. Stability of the radiopharmaceutical [99mTc]DMSA: study of the ligand exchange reaction with [99Tc]EDTA.
Garcia Muñoz M; Garcia Domenech R; Galvez Alvarez J; Moreno Frigols J
Int J Appl Radiat Isot; 1983 Nov; 34(11):1505-8. PubMed ID: 6315599
[TBL] [Abstract][Full Text] [Related]
46. [Determination of differential renal function using 99m Tc-DMSA scintigraphy].
Kraft O; Kuba J
Vnitr Lek; 1992 Feb; 38(2):140-7. PubMed ID: 1317621
[TBL] [Abstract][Full Text] [Related]
47. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
48. [The development of new tumor imaging 99mTc (V)-DMS kit: preparation and labeling condition studies].
Yomoda I; Horiuchi K; Hata N; Masuda H; Yokoyama A; Ogawa H; Nakazawa N; Ooi T
Kaku Igaku; 1987 Jan; 24(1):77-82. PubMed ID: 3033361
[No Abstract] [Full Text] [Related]
49. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC).
Guerra U; Pizzocaro C; Terzi A; Giubbini R; Bestagno M
J Nucl Med Allied Sci; 1988; 32(4):242-7. PubMed ID: 2852709
[No Abstract] [Full Text] [Related]
50. Search for polynuclear pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS] tumour localization mechanism. I. Medullary thyroid carcinoma animal model.
Horiuchi K; Yomoda I; Ohta H; Endo K; Yokoyama A
Eur J Nucl Med; 1991; 18(10):796-800. PubMed ID: 1660401
[TBL] [Abstract][Full Text] [Related]
51. Technetium-99m pentavalent DMSA imaging detects metastases of poorly differentiated carcinoma of the thyroid.
Costa DC; Glynne-Jones R; Falzon M; Lui D; Ryder JP; Ell PJ
Clin Nucl Med; 1989 Mar; 14(3):218-21. PubMed ID: 2544341
[No Abstract] [Full Text] [Related]
52. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
[TBL] [Abstract][Full Text] [Related]
53. A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA).
Westera G; Gadze A; Horst W
Int J Appl Radiat Isot; 1985 Apr; 36(4):311-2. PubMed ID: 2991143
[TBL] [Abstract][Full Text] [Related]
54. Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA.
Hirano T; Otake H; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1997 Jan; 38(1):20-6. PubMed ID: 8998143
[TBL] [Abstract][Full Text] [Related]
55. Preparation and evaluation of (99m)Tc-DMSA lyophilized kit for renal imaging.
Jan SU; Abbass HG
Pak J Pharm Sci; 2013 May; 26(3):547-51. PubMed ID: 23625428
[TBL] [Abstract][Full Text] [Related]
56. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
57. Technetium 99m dimercaptosuccinic acid scintigraphy in medullary carcinoma of the thyroid.
Scher RL; Eisele DW; Sostre S
Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):900-3. PubMed ID: 8239354
[No Abstract] [Full Text] [Related]
58. 99mTechnetium(V) dimercaptosuccinic acid (99mTc(v) DMSA) as a tumour seeking agent in nasopharyngeal carcinoma.
Aw SE; Sundram FX; Goh AS
Ann Acad Med Singap; 1986 Oct; 15(4):498-501. PubMed ID: 3032068
[TBL] [Abstract][Full Text] [Related]
59. Technetium 99m pentavalent dimercaptosuccinic acid and thallium 201 in detecting recurrent medullary carcinoma of the thyroid.
Bigsby RJ; Lepp EK; Litwin DE; Wilkinson AA; Matte GG
Can J Surg; 1992 Aug; 35(4):388-92. PubMed ID: 1323381
[TBL] [Abstract][Full Text] [Related]
60. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
